Optimal duration of urinary drainage after rectal resection: a randomized controlled trial.
S Benoist, Y Panis, C Denet...
https://pubmed.ncbi.nlm.nih.gov/10026745Actively Recruiting
Led by University of Southern California · Updated on 2026-02-05
176
Participants Needed
2
Research Sites
52 weeks
Total Duration
Researchers are evaluating the optimal duration of urinary catheter use after pelvic colorectal surgery, specifically total mesorectal excision (TME). This study aims to compare whether removing the catheter on the first day after surgery is as safe as the current standard of removing it on the third day. The goal is to reduce complications like urinary retention, urinary tract infections, and longer hospital stays, while improving recovery. This is a prospective, randomized, non-inferiority trial conducted by the University of Southern California. Participants undergoing TME will be randomly assigned to two groups: one with catheter removal on postoperative day 1 (experimental group) and the other with removal on day 3 (control group). Catheter removal is scheduled at 9 AM on the assigned days. The study involves standard care during and after surgery, including intravenous fluids and monitoring. The main comparison focuses on urinary retention rates, while secondary measures include urinary tract infections and hospital stay length. During the hospital stay, researchers will monitor urinary retention by checking if patients can urinate within 6 hours after catheter removal and using bladder scans if needed. Urinary tract infections will be diagnosed based on symptoms and urine cultures, treated as standard. Data on patient demographics, surgery details, and outcomes will be collected until discharge, which marks the study endpoint. The average hospital stay is about 4 days, and no follow-up is required after discharge.
CONDITIONS
Duration of Urinary Catheterization
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit (perioperative)
Duration - Day of surgery to postoperative day 1 or 3 (depending on group assignment)
Participants undergo total mesorectal excision surgery and receive urinary catheterization during and after surgery as part of standard care.
Hospital stay with daily monitoring
Duration - Up to 3 days post-surgery until catheter removal and monitoring
Participants have their urinary catheter removed either on postoperative day 1 (experimental group) or postoperative day 3 (control group). They are monitored for urinary retention and urinary tract infections.
Hospital stay with daily assessments
Duration - Until hospital discharge (average 4 days post-surgery)
Participants are observed in the hospital until discharge to monitor for urinary retention, urinary tract infections, and length of hospital stay.
Daily hospital visits and assessments until discharge
Total: 2 locations
1
Keck Hospital of USC
Los Angeles, California, United States, 90033
Actively Recruiting
2
Los Angeles County Hospital (LAC/USC)
Los Angeles, California, United States, 90033
Actively Recruiting
S
Sarah Koller, MD
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
S Benoist, Y Panis, C Denet...
https://pubmed.ncbi.nlm.nih.gov/10026745Byung Eun Yoo, Bong Hyeon Kye, Hyung Jin Kim...
https://pubmed.ncbi.nlm.nih.gov/26200683Devin N Patel, Seth I Felder, Michael Luu...
https://pubmed.ncbi.nlm.nih.gov/30192326Mary R Kwaan, Janet T Lee, David A Rothenberger...
https://pubmed.ncbi.nlm.nih.gov/25751796Cindy Kin, Kim F Rhoads, Moe Jalali...
https://pubmed.ncbi.nlm.nih.gov/23652748Jeehyoung Kim, Wonshik Shin
https://pubmed.ncbi.nlm.nih.gov/24605197Daniel Dindo, Nicolas Demartines, Pierre-Alain Clavien
https://pubmed.ncbi.nlm.nih.gov/15273542